110 related articles for article (PubMed ID: 9561912)
1. Malignant histiocytosis. Histologic, cytochemical, chromosomal, and molecular data with a nosologic discussion.
Gogusev J; Nezelof C
Hematol Oncol Clin North Am; 1998 Apr; 12(2):445-63. PubMed ID: 9561912
[TBL] [Abstract][Full Text] [Related]
2. The 5q35bp chromosomal abnormality characterizes certain CD30 positive anaplastic large cell lymphomas offering a new definition of malignant histiocytosis in childhood.
Nezelof C
Nouv Rev Fr Hematol (1978); 1993; 35(5):463-7. PubMed ID: 8295819
[TBL] [Abstract][Full Text] [Related]
3. [Toward a new definition of malignant histiocytosis in children].
Nezelof C
Bull Mem Acad R Med Belg; 1992; 147(11-12):472-8; discussion 478-80. PubMed ID: 1341571
[TBL] [Abstract][Full Text] [Related]
4. Malignant histiocytosis in childhood: a distinctive CD30-positive clinicopathological entity associated with a chromosomal translocation involving 5q35.
Nezelof C; Barbey S; Gogusev J; Terrier-Lacombe MJ
Semin Diagn Pathol; 1992 Feb; 9(1):75-89. PubMed ID: 1313990
[TBL] [Abstract][Full Text] [Related]
5. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis.
Morgan R; Smith SD; Hecht BK; Christy V; Mellentin JD; Warnke R; Cleary ML
Blood; 1989 Jun; 73(8):2155-64. PubMed ID: 2525056
[TBL] [Abstract][Full Text] [Related]
6. A T-cell neoplasia showing clinicopathologic features of malignant histiocytosis with novel chromosomal abnormalities and N-ras mutation.
Itoyama T; Sadamori N; Sasagawa I; Nakamura H; Tokunaga S; Yamada Y; Ichimaru M; Yoshida T; Kikuchi M; Takeshima F
Cancer; 1991 Apr; 67(8):2103-10. PubMed ID: 2004329
[TBL] [Abstract][Full Text] [Related]
7. Genotype markers and proto-oncogene analysis in the CD30-positive "malignant histiocytosis" DEL cell line with t(5;6)(q35;p21).
Gogusev J; Barbey S; Nezelof C
Int J Cancer; 1990 Jul; 46(1):106-12. PubMed ID: 2163988
[TBL] [Abstract][Full Text] [Related]
8. The t(2;5) in human lymphomas.
Kadin ME; Morris SW
Leuk Lymphoma; 1998 Apr; 29(3-4):249-56. PubMed ID: 9684923
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas.
Ott G; Katzenberger T; Siebert R; DeCoteau JF; Fletcher JA; Knoll JH; Kalla J; Rosenwald A; Ott MM; Weber-Matthiesen K; Kadin ME; Müller-Hermelink HK
Genes Chromosomes Cancer; 1998 Jun; 22(2):114-21. PubMed ID: 9598798
[TBL] [Abstract][Full Text] [Related]
10. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
Dirks WG; Zaborski M; Jäger K; Challier C; Shiota M; Quentmeier H; Drexler HG
Leukemia; 1996 Jan; 10(1):142-9. PubMed ID: 8558920
[TBL] [Abstract][Full Text] [Related]
11. Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies.
Wilson MS; Weiss LM; Gatter KC; Mason DY; Dorfman RF; Warnke RA
Cancer; 1990 Aug; 66(3):530-6. PubMed ID: 2194647
[TBL] [Abstract][Full Text] [Related]
12. The t(2;5)-associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders.
Su LD; Schnitzer B; Ross CW; Vasef M; Mori S; Shiota M; Mason DY; Pulford K; Headington JT; Singleton TP
J Cutan Pathol; 1997 Nov; 24(10):597-603. PubMed ID: 9449486
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
Nakamura S; Shiota M; Nakagawa A; Yatabe Y; Kojima M; Motoori T; Suzuki R; Kagami Y; Ogura M; Morishima Y; Mizoguchi Y; Okamoto M; Seto M; Koshikawa T; Mori S; Suchi T
Am J Surg Pathol; 1997 Dec; 21(12):1420-32. PubMed ID: 9414185
[TBL] [Abstract][Full Text] [Related]
14. The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma.
Johnson PW; Leek J; Swinbank K; Angus B; Roberts P; Markham AF; Selby PJ; MacLennan KA
Ann Oncol; 1997; 8 Suppl 2():65-9. PubMed ID: 9209644
[TBL] [Abstract][Full Text] [Related]
15. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
Beylot-Barry M; Lamant L; Vergier B; de Muret A; Fraitag S; Delord B; Dubus P; Vaillant L; Delaunay M; MacGrogan G; Beylot C; de Mascarel A; Delsol G; Merlio JP
Am J Pathol; 1996 Aug; 149(2):483-92. PubMed ID: 8701987
[TBL] [Abstract][Full Text] [Related]
16. Malignant histiocytosis: a reassessment of cases formerly classified as histiocytic neoplasms and review of the literature.
Egeler RM; Schmitz L; Sonneveld P; Mannival C; Nesbit ME
Med Pediatr Oncol; 1995 Jul; 25(1):1-7. PubMed ID: 7752995
[TBL] [Abstract][Full Text] [Related]
17. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
Luthra R; Pugh WC; Waasdorp M; Morris W; Cabanillas F; Chan PK; Sarris AH
Hematopathol Mol Hematol; 1998; 11(3-4):173-83. PubMed ID: 9844824
[TBL] [Abstract][Full Text] [Related]
18. NPM/ALK gene fusion transcripts identify a distinct subgroup of null type Ki-1 positive anaplastic large cell lymphomas.
Simonitsch I; Panzer-Gruemayer ER; Ghali DW; Zoubek A; Radaszkiewicz T; Gadner H; Kovar H
Br J Haematol; 1996 Mar; 92(4):866-71. PubMed ID: 8616079
[TBL] [Abstract][Full Text] [Related]
19. Malignant histiocytosis: a specific t(2;5)(p23;q35) translocation? Review of the literature.
Benz-Lemoine E; Brizard A; Huret JL; Babin P; Guilhot F; Couet D; Tanzer J
Blood; 1988 Sep; 72(3):1045-7. PubMed ID: 3416066
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
Shiota M; Mori S
Leukemia; 1997 Apr; 11 Suppl 3():538-40. PubMed ID: 9209450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
